Two Biologics on Par for Controlling Arthralgias in IBD
Two Biologics on Par for Controlling Arthralgias in IBD 3AUSTIN — Vedolizumab (Entyvio) was just as effective as infliximab (Remicade) in controlling arthralgias among patients with inflammatory bowel disease (IBD), according to a head-to-head comparison presented here. Among 154 biologic-naive adults with Crohn’s disease or ulcerative colitis, there was no difference in the rate of new-onset …
News story posted on 2020-01-25T23:18:00.0000000Z